Literature DB >> 34806876

N501Y and K417N Mutations in the Spike Protein of SARS-CoV-2 Alter the Interactions with Both hACE2 and Human-Derived Antibody: A Free Energy of Perturbation Retrospective Study.

Filip Fratev1,2.   

Abstract

The N501Y and K417N mutations in the spike protein of SARS-CoV-2 and their combination gave rise to questions, but the data on their mechanism of action at the molecular level were limited. In this study, we present free energy perturbation (FEP) calculations, performed at the end of December 2020, for the interactions of the spike S1 receptor-binding domain (RBD) with both the ACE2 receptor and an antibody derived from COVID-19 patients. Our results showed that the S1 RBD-ACE2 interactions were significantly increased whereas those with the STE90-C11 antibody dramatically decreased. The K417N mutation in a combination with N501Y fully abolished the antibody effect. However, Lys417Asn seems to have a compensatory mechanism of action increasing the S1 RBD-ACE2 free energy of binding. This may explain the increased spread of the virus observed in the U.K. and South Africa and also gives rise to an important question regarding the possible human immune response and the success of the already available vaccines. Notably, when the experimental data became available confirming our calculations, it was demonstrated that protein-protein FEP can be a useful tool for providing urgent data to the scientific community.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34806876     DOI: 10.1021/acs.jcim.1c01242

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  27 in total

1.  Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.

Authors:  Mohamed Haddad; Roger Gaudreault; Gabriel Sasseville; Phuong Trang Nguyen; Hannah Wiebe; Theo Van De Ven; Steve Bourgault; Normand Mousseau; Charles Ramassamy
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

Review 2.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

3.  Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.

Authors:  Chad D Fibke; Yayuk Joffres; John R Tyson; Caroline Colijn; Naveed Z Janjua; Chris Fjell; Natalie Prystajecky; Agatha Jassem; Hind Sbihi
Journal:  Front Public Health       Date:  2022-07-04

4.  COVID-19 Delta variants-Current status and implications as of August 2021.

Authors:  Flora Yu; Lok-Ting Lau; Manson Fok; Johnson Yiu-Nam Lau; Kang Zhang
Journal:  Precis Clin Med       Date:  2021-09-20

Review 5.  Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.

Authors:  Daniele Focosi; Fabrizio Maggi
Journal:  Rev Med Virol       Date:  2021-03-16       Impact factor: 11.043

Review 6.  The role of nanotechnology in current COVID-19 outbreak.

Authors:  Shima Tavakol; Masoumeh Zahmatkeshan; Reza Mohammadinejad; Saeed Mehrzadi; Mohammad T Joghataei; Mo S Alavijeh; Alexander Seifalian
Journal:  Heliyon       Date:  2021-04-15

7.  Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations.

Authors:  Damiano Buratto; Abhishek Saxena; Qun Ji; Guang Yang; Sergio Pantano; Francesco Zonta
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 8.  Covid-19 vaccines and variants of concern: A review.

Authors:  Ikbel Hadj Hassine
Journal:  Rev Med Virol       Date:  2021-11-09       Impact factor: 11.043

9.  In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential.

Authors:  Brandon Lam; Yu Jui Kung; John Lin; Ssu-Hsueh Tseng; Ya Chea Tsai; Liangmei He; Gianni Castiglione; Emily Egbert; Elia J Duh; Evan M Bloch; Aaron A R Tobian; Aaron M Milstone; Richard B S Roden; Tzyy-Choou Wu; Chien-Fu Hung
Journal:  Cell Rep       Date:  2021-10-05       Impact factor: 9.423

10.  Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach.

Authors:  Reem Y Aljindan; Abeer M Al-Subaie; Ahoud I Al-Ohali; Thirumal Kumar D; George Priya Doss C; Balu Kamaraj
Journal:  Comput Biol Med       Date:  2021-07-16       Impact factor: 4.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.